Neurocrine Biosciences (NBIX) R&D In Process: 2019-2020
Historic R&D In Process for Neurocrine Biosciences (NBIX) over the last 1 years, with Sep 2020 value amounting to $118.5 million.
- Neurocrine Biosciences' R&D In Process was N/A to $118.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $272.8 million, marking a year-over-year change of. This contributed to the annual value of $154.3 million for FY2019, which is 3147.83% up from last year.
- According to the latest figures from Q3 2020, Neurocrine Biosciences' R&D In Process is $118.5 million, which was up 227.60% from $36.2 million recorded in Q4 2019.
- In the past 5 years, Neurocrine Biosciences' R&D In Process registered a high of $118.5 million during Q3 2020, and its lowest value of $5.0 million during Q2 2019.
- Its 2-year average for R&D In Process is $68.2 million, with a median of $74.6 million in 2019.